CDC’s Questionable Legionnaires’ Policy
NEW YORK—Deaths have resulted from a conscious, long-standing Centers for Disease Control and Prevention (CDC) policy on how to address Legionnaires’ disease, according to an opinion article in Forbes. According to the author, a former biomedical scientist and FDA drug regulator, the CDC’s recommendations for preventing Legionnaires’ disease have been predominantly focused on a disease surveillance strategy—a reactive process that relies on screening for disease after cases are detected and taking action to prevent further infections. Although this strategy works well for person-to-person transmissible diseases, it is not well suited to situations in which the source of disease is in the environment.
Follow & Share!
